Literature DB >> 19371271

Ghrelin and leptin modulate immunity and liver function in overweight children.

Yuki Okamatsu1, Kentaro Matsuda, Ikue Hiramoto, Hidekazu Tani, Koichi Kimura, Yoichi Yada, Tatsuyuki Kakuma, Sadanobu Higuchi, Masayasu Kojima, Toyojiro Matsuishi.   

Abstract

BACKGROUND: The rising prevalence of obesity represents a growing worldwide public health problem. Interactions of adipocytokines and low-grade systemic inflammation presently are considered important in the development of obesity, as well as associated chronic disease including bronchial asthma, obesity-related liver disease and type 2 diabetes mellitus. The purpose of the present study was to investigate metabolic, hormonal, immunologic and inflammatory factors in overweight children and to further clarify possible immunomodulatory effects of obesity-related hormones and cytokines.
METHODS: Forty-nine prepubertal overweight children and 49 age-matched controls of normal weight without underlying disease were enrolled. Levels of plasma ghrelin and serum leptin, cytokines (interleukin [IL]-4, IL-10, IL-12, 1L-13), C-reactive protein, immunoglobulin, and insulin were measured, and liver function tests were done to better understand their status in the setting of obesity.
RESULTS: Overweight subjects had significantly higher measures of adiposity (body mass indexI, % body fat) and had significantly higher serum levels of IgG, IgA and IgE than non-obese children (P = 0.038, 0.0043, 0.0034, respectively); the opposite was true for IgM (P = 0.025). The incidence of presumed non-alcoholic fatty liver disease was 28.6% in overweight children. In overweight children, serum leptin levels were associated with liver function index (aspartate aminotransferase/alanine aminotransferase ratio) and serum insulin levels. Some elevated immunoglobulin levels significantly correlated with plasma ghrelin levels and liver function index.
CONCLUSIONS: It is possible that appetite-regulating hormones modulate both humoral immunity and liver function. Further studies with a larger number of subjects are needed to clarify the precise mechanisms of this association.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371271     DOI: 10.1111/j.1442-200X.2008.02647.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Ghrelin: a new treatment for non-alcoholic fatty liver disease?

Authors:  Patric J D Delhanty; Aart J van der Lely
Journal:  Endocrine       Date:  2012-09-20       Impact factor: 3.633

2.  Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents.

Authors:  Rafael Vázquez-Solórzano; Elia Valdés-Miramontes; Mildren Porchas-Quijada; Mayra Enciso-Ramírez; Guadalupe A Contreras-Mata; Alma Gabriela Martínez-Moreno; Lourdes Barajas-García; Astrid Selene Espinoza-García; Zyanya Reyes-Castillo
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 3.  Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides.

Authors:  L Kořínková; V Pražienková; L Černá; A Karnošová; B Železná; J Kuneš; Lenka Maletínská
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555

Review 4.  Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers.

Authors:  Aldona Kasprzak; Agnieszka Adamek
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

5.  Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma?

Authors:  Nazan Cobanoglu; Nilufer Galip; Ceyhun Dalkan; Nerin Nadir Bahceciler
Journal:  Multidiscip Respir Med       Date:  2013-09-25

6.  Serum Ghrelin Levels in Saudi Obese Asthmatic School-Children-Correlation with Interleukin-4, Interleukin-5, and Interleukin-21.

Authors:  Mohammed Saeed Al-Ayed; Khaled Sadeq Al-Shaibari; Dhafer Alshehri; Mohammed Jamaan Alzahrani; Iman Nasser; Hamdan Saad Alaamri; Wed Ahmad Alaseeri; Ahmed A Mahfouz; Saeed Ali Alsareii; Ahmed Morad Asaad; Aamir Magzoub; Mohammed Ansar Qureshi; Ehab Elagab; Elhashimi Eltayb Hassan; Mohammed Helmy Faris Shalayel
Journal:  Int J Environ Res Public Health       Date:  2020-03-04       Impact factor: 3.390

7.  Longitudinal association of the anti-inflammatory serum marker GDF-15 with serum IgA and IgG in apparently healthy children.

Authors:  Judit Bassols; Abel López-Bermejo; Gemma Carreras-Badosa; Ariadna Gómez-Vilarrubla; Berta Mas-Parés; Silvia Xargay-Torrent; Anna Prats-Puig; Elsa Puerto-Carranza; Francis de Zegher; Lourdes Ibáñez
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.